INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
30 oct. 2024 21h10 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
30 oct. 2024 21h09 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Metagenomi To Contact Him Directly To Discuss Their Options If...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28
30 oct. 2024 20h42 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
30 oct. 2024 17h46 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elanco To Contact Him Directly To Discuss Their Options ...
VitalHub Announces Acquisition of Strata Health
30 oct. 2024 16h30 HE
|
VitalHub Corp.
TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Strata Health...
Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors
30 oct. 2024 08h00 HE
|
Numab Therapeutics AG
NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological malignancies Low molecular...
KFSHRC Leading Healthcare Innovation and Transformation in Saudi Arabia
30 oct. 2024 07h48 HE
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Leading Healthcare Innovation and Transformation in Saudi Arabia
Lynch Carpenter Investigates Claims in ATSG Data Breach
29 oct. 2024 13h03 HE
|
Lynch Carpenter
PITTSBURGH, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Lynch Carpenter, LLP is investigating a class action against ATSG, Inc. regarding a recently announced data breach. The ATSG data breach may have...
RMS Sponsors the 5th Summit on Stem Cell Derived Islets
29 oct. 2024 09h00 HE
|
Regenerative Medical Solutions
Boston, MA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Regenerative Medical Solutions (RMS) is sponsoring the 5th Summit on Stem Cell Derived Islets, which will be held on October 28-29 at the Joseph B....
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
29 oct. 2024 08h30 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference